Share this post on:

Name :
IRAK4 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
IRAK4 Rabbit Polyclonal antibody. Positive WB detected in K-562 cells, Jurkat cells. Positive IP detected in K-562 cells. Observed molecular weight by Western-blot: 52 kDa

Tested applications :
ELISA, WB, IP, IHC

Species reactivity :
Human,Mouse,Rat; other species not tested.

Alternative names :
IPD1 antibody; IRAK 4 antibody; IRAK4 antibody; NY REN 64 antibody; REN64 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of IRAK4 recombinant protein (Accession Number: XM_017019390). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:1000IP: 1:200-1:1000IHC: 1:50-1:500

Background :
IRAK4 represents interleukin-1 receptor-associated kinase 4

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Zalutumumab
CD133 Antibody
MGMT Antibody: MGMT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 22 kDa, targeting to MGMT. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Share this post on:

Author: Gardos- Channel